Logo image of TALK

TALKSPACE INC (TALK) Stock Fundamental Analysis

NASDAQ:TALK - US87427V1035 - Common Stock

2.61 USD
-0.02 (-0.76%)
Last: 9/5/2025, 8:00:01 PM
2.6 USD
-0.01 (-0.38%)
After Hours: 9/5/2025, 8:00:01 PM
Fundamental Rating

5

Taking everything into account, TALK scores 5 out of 10 in our fundamental rating. TALK was compared to 101 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for TALK as it has an excellent financial health rating, but there are worries on the profitability. TALK is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year TALK was profitable.
TALK had a positive operating cash flow in the past year.
In the past 5 years TALK reported 4 times negative net income.
In the past 5 years TALK reported 4 times negative operating cash flow.
TALK Yearly Net Income VS EBIT VS OCF VS FCFTALK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

TALK has a Return On Assets of 2.16%. This is comparable to the rest of the industry: TALK outperforms 58.42% of its industry peers.
TALK has a Return On Equity of 2.54%. This is comparable to the rest of the industry: TALK outperforms 56.44% of its industry peers.
Industry RankSector Rank
ROA 2.16%
ROE 2.54%
ROIC N/A
ROA(3y)-21.22%
ROA(5y)-31.96%
ROE(3y)-25.9%
ROE(5y)-58.19%
ROIC(3y)N/A
ROIC(5y)N/A
TALK Yearly ROA, ROE, ROICTALK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

TALK has a better Profit Margin (1.41%) than 60.40% of its industry peers.
With a decent Gross Margin value of 44.34%, TALK is doing good in the industry, outperforming 72.28% of the companies in the same industry.
In the last couple of years the Gross Margin of TALK has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 1.41%
GM 44.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.99%
GM growth 5Y-2.76%
TALK Yearly Profit, Operating, Gross MarginsTALK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

8

2. Health

2.1 Basic Checks

TALK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TALK has more shares outstanding
Compared to 5 years ago, TALK has more shares outstanding
TALK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TALK Yearly Shares OutstandingTALK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
TALK Yearly Total Debt VS Total AssetsTALK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 12.77 indicates that TALK is not in any danger for bankruptcy at the moment.
TALK has a better Altman-Z score (12.77) than 95.05% of its industry peers.
There is no outstanding debt for TALK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.77
ROIC/WACCN/A
WACC8.74%
TALK Yearly LT Debt VS Equity VS FCFTALK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 6.51 indicates that TALK has no problem at all paying its short term obligations.
TALK has a Current ratio of 6.51. This is amongst the best in the industry. TALK outperforms 95.05% of its industry peers.
A Quick Ratio of 6.51 indicates that TALK has no problem at all paying its short term obligations.
TALK's Quick ratio of 6.51 is amongst the best of the industry. TALK outperforms 95.05% of its industry peers.
Industry RankSector Rank
Current Ratio 6.51
Quick Ratio 6.51
TALK Yearly Current Assets VS Current LiabilitesTALK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

8

3. Growth

3.1 Past

TALK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 140.00%, which is quite impressive.
TALK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.43%.
TALK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.48% yearly.
EPS 1Y (TTM)140%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
Revenue 1Y (TTM)17.43%
Revenue growth 3Y18.16%
Revenue growth 5Y37.48%
Sales Q2Q%17.92%

3.2 Future

The Earnings Per Share is expected to grow by 168.61% on average over the next years. This is a very strong growth
TALK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.05% yearly.
EPS Next Y308%
EPS Next 2Y232.41%
EPS Next 3Y168.61%
EPS Next 5YN/A
Revenue Next Year19.26%
Revenue Next 2Y20.06%
Revenue Next 3Y19.32%
Revenue Next 5Y21.05%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
TALK Yearly Revenue VS EstimatesTALK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
TALK Yearly EPS VS EstimatesTALK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 130.50, TALK can be considered very expensive at the moment.
TALK's Price/Earnings ratio is in line with the industry average.
TALK's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.06.
With a Price/Forward Earnings ratio of 23.62, TALK is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TALK is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, TALK is valued at the same level.
Industry RankSector Rank
PE 130.5
Fwd PE 23.62
TALK Price Earnings VS Forward Price EarningsTALK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of TALK is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 479.8
EV/EBITDA N/A
TALK Per share dataTALK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

TALK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TALK's earnings are expected to grow with 168.61% in the coming years.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y232.41%
EPS Next 3Y168.61%

More info and screens

0

5. Dividend

5.1 Amount

TALK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TALKSPACE INC

NASDAQ:TALK (9/5/2025, 8:00:01 PM)

After market: 2.6 -0.01 (-0.38%)

2.61

-0.02 (-0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)10-27 2025-10-27/amc
Inst Owners58.37%
Inst Owner Change-0.89%
Ins Owners3.91%
Ins Owner Change-0.8%
Market Cap437.10M
Analysts81.54
Price Target4.9 (87.74%)
Short Float %3.67%
Short Ratio3.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.09%
Min Revenue beat(2)-1.85%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-2.09%
Min Revenue beat(4)-4.06%
Max Revenue beat(4)-0.33%
Revenue beat(8)3
Avg Revenue beat(8)0.39%
Revenue beat(12)6
Avg Revenue beat(12)0.99%
Revenue beat(16)7
Avg Revenue beat(16)-0.77%
PT rev (1m)0%
PT rev (3m)-4%
EPS NQ rev (1m)1.83%
EPS NQ rev (3m)-18.53%
EPS NY rev (1m)-11.11%
EPS NY rev (3m)-20%
Revenue NQ rev (1m)-0.22%
Revenue NQ rev (3m)2.8%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)-0.15%
Valuation
Industry RankSector Rank
PE 130.5
Fwd PE 23.62
P/S 2.16
P/FCF 479.8
P/OCF 50.26
P/B 3.87
P/tB 3.87
EV/EBITDA N/A
EPS(TTM)0.02
EY0.77%
EPS(NY)0.11
Fwd EY4.23%
FCF(TTM)0.01
FCFY0.21%
OCF(TTM)0.05
OCFY1.99%
SpS1.21
BVpS0.67
TBVpS0.67
PEG (NY)0.42
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.16%
ROE 2.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.41%
GM 44.34%
FCFM 0.45%
ROA(3y)-21.22%
ROA(5y)-31.96%
ROE(3y)-25.9%
ROE(5y)-58.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.99%
GM growth 5Y-2.76%
F-Score7
Asset Turnover1.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 431.06%
Cap/Sales 3.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 31.8%
Current Ratio 6.51
Quick Ratio 6.51
Altman-Z 12.77
F-Score7
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)224%
Cap/Depr(5y)197.42%
Cap/Sales(3y)1.1%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)140%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
EPS Next Y308%
EPS Next 2Y232.41%
EPS Next 3Y168.61%
EPS Next 5YN/A
Revenue 1Y (TTM)17.43%
Revenue growth 3Y18.16%
Revenue growth 5Y37.48%
Sales Q2Q%17.92%
Revenue Next Year19.26%
Revenue Next 2Y20.06%
Revenue Next 3Y19.32%
Revenue Next 5Y21.05%
EBIT growth 1Y83.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year474.33%
EBIT Next 3Y143.72%
EBIT Next 5Y109.41%
FCF growth 1Y102.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y120.84%
OCF growth 3YN/A
OCF growth 5YN/A